24 May 2013
Keywords: pharma, cut, aids, drug, prices, china, bristol-myers
Article | 04 December 2001
Bristol-Myers Squibb and GlaxoSmithKline are currently reported to bereadying significant price reductions on their HIV/AIDS drug treatments
in China, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 December 2001
5 December 2001
23 May 2013
© 2013 thepharmaletter.com